glp 1 network marketing GLP-1 2.0: Where the Next Wave of Value Will Be Created GLP-1 Agonists Weight Loss Drugs

Following the discovery of semaglutides effectiveness in inducing clinically meaningful weight loss, consumer and clinical demand for GLP-1s increased substantially

International Journal of Obesity, 39 (3), 424429

Patients with diabetes or at risk of diabetes should have baseline and periodic monitoring of fasting glucose or HbA1c, with potential adjustments to diabetes medications

I think that's what GLP-1 has an opportunity to do now

Testing may be appropriate if: Weight loss exceeds 1520% Fatigue, hair thinning or neuropathy develops Persistent vomiting or diarrhoea occurs Dietary intake becomes severely restricted You are in a higher-risk group (e.g., premenopausal women, older adults, GLP-1 + metformin users) Monitoring should be personalised rather than automatic